Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Blackwell

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
JCO Oncology Practice|June 12, 2023
Adapting to Change: A Thoracic Oncology Team's PerspectiveJeffrey Crawford, Susan Blackwell, Sally Yowell Barbour
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2014
Spontaneous mutagenesis assaySusan Blackwell, Michelle D Hanna, Wei Xiao
Mutation Research. Reviews in Mutation Research|June 5, 2015
Error-free DNA-damage tolerance in Saccharomyces cerevisiaeXin Xu, Susan Blackwell, Aiyang Lin, et al.
DNA Repair|March 29, 2014
The Rad5 helicase activity is dispensable for error-free DNA post-replication repairLindsay G Ball, Xin Xu, Susan Blackwell, et al.
Journal of Oncology Practice|September 23, 2010
Nonphysician providers in oncologyDavid Coniglio, Susan Blackwell, Sprague Cheshire, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Preoperative radiation therapy and chemotherapy for pulmonary blastoma: a case reportTimothy M Zagar, Susan Blackwell, Jeffrey Crawford, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancerRichard F Riedel, Carolyn Andrews, Jennifer Garst, et al.
Clinical Drug Investigation|December 14, 2006
A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancerJennifer Garst, James E Herndon, Timothy Shafman, et al.
Journal for Immunotherapy of Cancer|October 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitorsLing Zhu, Yee-Ming M Cheung, Cherie Chiang, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
JCO Oncology Practice|June 12, 2023
Adapting to Change: A Thoracic Oncology Team's PerspectiveJeffrey Crawford, Susan Blackwell, Sally Yowell Barbour
Methods in Molecular Biology (Clifton, N.J.)|May 21, 2014
Spontaneous mutagenesis assaySusan Blackwell, Michelle D Hanna, Wei Xiao
Mutation Research. Reviews in Mutation Research|June 5, 2015
Error-free DNA-damage tolerance in Saccharomyces cerevisiaeXin Xu, Susan Blackwell, Aiyang Lin, et al.
DNA Repair|March 29, 2014
The Rad5 helicase activity is dispensable for error-free DNA post-replication repairLindsay G Ball, Xin Xu, Susan Blackwell, et al.
Journal of Oncology Practice|September 23, 2010
Nonphysician providers in oncologyDavid Coniglio, Susan Blackwell, Sprague Cheshire, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 27, 2010
Preoperative radiation therapy and chemotherapy for pulmonary blastoma: a case reportTimothy M Zagar, Susan Blackwell, Jeffrey Crawford, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2007
A phase II trial of carboplatin/vinorelbine with pegfilgrastim support for the treatment of patients with advanced non-small cell lung cancerRichard F Riedel, Carolyn Andrews, Jennifer Garst, et al.
Clinical Drug Investigation|December 14, 2006
A phase I study of dose-dense topotecan given upfront to standard therapy in patients with small cell lung cancerJennifer Garst, James E Herndon, Timothy Shafman, et al.
Journal for Immunotherapy of Cancer|October 15, 2025
Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitorsLing Zhu, Yee-Ming M Cheung, Cherie Chiang, et al.
Pageof 1